IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Dieter Heldmann

USPTO Granted Patents = 12 

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 473(Granted Patents)


Location History:

  • 10555 Berlin, DE (2002)
  • Berlin, DE (1995 - 2004)

Company Filing History:

goldMedal8 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 2 
 
Schering Aktiengesellchaft
 patents
bronzeMedal1 out of 1 
 
Scharing Aktiengesellschaft
 patent
4. 2 out of 832,680 
Other
 patents

Years Active: 1995-2004

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6709693 - Stents with a radioactive surface coating, processes for their production and their use for restenosis prophylaxis (2004-03-23),
2. 6488909 - Chelating agents as well as their tricarbonyl complexes with technetium and rhenium (2002-12-03),
3. 6436365 - Process for therapeutic treatment of proliferative diseases (2002-08-20),
4. 6383470 - Microparticle preparations made of biodegradable copolymers (2002-05-07),
5. 6319488 - Contrast medium for near infrared diagnosis (2001-11-20),
6. 6306366 - Microparticles that contain gas, galactose and a saturated fatty acid (2001-10-23),
7. 6284280 - Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production (2001-09-04),
8. 6264959 - Ultrasonic contrast agents, process for their preparation and their use as a diagnostic and therapeutic agent (2001-07-24),
9. 6177062 - Agents and methods for enhancing contrast in ultrasound imaging (2001-01-23),
10. 6071496 - Polyalkylcyanoacrylate agents and methods for enhancing contrast in (2000-06-06),
11. 6068857 - Microparticles containing active ingredients, agents containing these (2000-05-30),
12. 5425366 - Ultrasonic contrast agents for color Doppler imaging (1995-06-20),

Title: The Innovative Contributions of Dieter Heldmann

Introduction

Dieter Heldmann is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medical technology, particularly in the development of advanced stents and chelating agents. With a total of 12 patents to his name, Heldmann's work has had a profound impact on radiodiagnosis and radiotherapy.

Latest Patents

Among his latest patents, Heldmann has developed stents with a radioactive surface coating. This invention relates to radioactive stents characterized by a surface coating of radioactive isotopes, along with processes for their production and use in restenosis prophylaxis. Additionally, he has created new chelating agents and their tricarbonyl complexes with technetium and rhenium. These compounds are designed for use in radiodiagnosis and radiotherapy, specifically targeting diseased tissue.

Career Highlights

Throughout his career, Heldmann has worked with notable companies, including Schering Aktiengesellschaft. His innovative approaches have led to advancements in medical treatments and diagnostic techniques, showcasing his expertise in the field.

Collaborations

Heldmann has collaborated with esteemed colleagues such as Thomas Fritzsch and Joachim Siegert. These partnerships have further enhanced the development and application of his inventions.

Conclusion

Dieter Heldmann's contributions to medical technology through his patents and collaborations have established him as a key figure in the field. His work continues to influence advancements in healthcare and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…